Hospira Carboplatin I.V. Infusion 150mg/15mL single dose vial

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

carboplatin, Quantity: 10 mg/mL

Disponible des:

Hospira Australia Pty Ltd

Designació comuna internacional (DCI):

Carboplatin

formulario farmacéutico:

Injection, intravenous infusion

Composición:

Excipient Ingredients: water for injections

Vía de administración:

Intravenous Infusion

Unidades en paquete:

1 x 15 mL

clase:

Medicine Listed (Export Only)

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Head and neck cancer, small cell lung cancer, testicular cancer, ovarian cancer, uterine cancer, malignant lymphoma, non-small cell lung cancer, breast cancer Used in conjunction with other antineoplastic drugs for the following malignant tumours: Paediatric solid malignant tumours (neuroblastoma/retinoblastoma/ hepatoblastoma/central nervous system neuroblastoma, recurrent or refractory Ewing?s sarcoma family tumours/nephroblastoma)

Resumen del producto:

Visual Identification: Carboplatin Injection is a clear, colourless or pale yellow liquid.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2013-10-09